RxDoctor Payments Data

Patricia Flynn

Pediatric Infectious Diseases · Memphis, TNNPI 1609879865

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,926 of the $14,926 with a category attached, or 100.0%. Merck accounts for 82.6% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $7,913 and has fallen 89.3% since, to $850 in 2024.

$14,926in general payments, 2019–2025

Across 9 payments — averaging $1658.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$12K
  • Viiv Healthcare Company$3K
$17,386,146in research payments, 2019–2025

Across 21 payments — averaging $827,912 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Viiv Healthcare Company$17.4M
  • Janssen Research & Development, LLC$23K

What the payments were for

  • Consulting fees$14,926100%

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck8$12,326
Viiv Healthcare Company1$2,600

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,926 in reported general payments places this provider in the 80th percentile of 36 pediatric infectious diseases providers in Tennessee.

See all pediatric infectious diseases providers in Tennessee

Other pediatric infectious diseases in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →